UTHR News and Press, United Therapeutics Corporation From 03/05/24

2024-03-05 20:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that Patrick Poisson , Executive Vice President, Technical Operations, will provide an overview and update on the company’s operations during a fireside chat session at the Leerink Partne...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that Michael Benkowitz , President and Chief Operating Officer, will provide an overview and update on the company’s operations during a fireside chat session at the TD Cowen 44 th An...

2024-02-24 06:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-21 14:56:05 ET United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript February 21, 2024 09:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairperson & Chief Executive Officer Michael Ben...

2024-02-21 06:02:03 ET More on United Therapeutics Anticompetitive Behavior At United Therapeutics United Therapeutics: Cheap With Litigation Headwinds Liquidia jumps on win in patent case against United Therapeutics (update) Seeking Alpha’s Quant Rati...

Vimeo Inc. (VMEO) is expected to report $-0.01 for Q4 2023 Heineken N.V ADR (HEINY) is expected to report for Q4 2023 American States Water Company (AWR) is expected to report $0.53 for Q4 2023 NextPlay Technologies Inc. (NXTP) is expected to report for Q3 2024 Inseego Corp. (INSG...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2023. Full year 2023 revenues rose to a record $2.33 billion, reflecting 20% growth over 2022. “Congratulations to the de...

United Therapeutics Corporation (Nasdaq: UTHR ) announced today the commencement of litigation with the United States Food and Drug Administration ( FDA ). In the litigation, United Therapeutics alleges that the FDA mistakenly permitted Liquidia Corporation ( Liquidia ) to skirt longs...

2024-02-20 11:20:24 ET More on United Therapeutics Anticompetitive Behavior At United Therapeutics United Therapeutics: Cheap With Litigation Headwinds Liquidia jumps on win in patent case against United Therapeutics (update) The most crowded pharma longs and...